Overview
Clinical Framing
Metformin remains the foundational agent for T2DM, but 50% of patients require intensification within 3 years.
FNP
FNP
Metformin remains the foundational agent for T2DM, but >50% of patients require intensification within 3 years. The NP's challenge at intensification is not just picking an antihyperglycemic — it is selecting the agent that simultaneously treats the most important comorbidity risk. GLP-1 receptor agonists and SGLT-2 inhibitors have transformed T2DM management by offering cardiovascular and renal protection independent of A1c lowering. Knowing when and how to prescribe these agents, including dosing, monitoring, and contraindications, is now core NP competency.
Unlock full lesson + practice questions
5 more sections with scenarios, priorities, and review drills.
Final rapid review before practice
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this FNP pathway. You can still explore topic-filtered questions from the bank hubs below.